Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 02, 2015 4:57 AM ET

Capital Markets

Company Overview of Brandon Capital Partners

Company Overview

Brandon Capital Partners is a venture capital firm specializing in seed stage, startup, growth capital, early venture, and mid venture investments. It prefers to invest in the life sciences, biotech, new drug discovery, and medical devices sectors. It invests in firms based in Australia. The firm seeks to invest between $160,000 and $40.38 million. Brandon Capital Partners was founded in 1999 and is based in Sydney, Australia with an additional office in Melbourne, Australia.

Level 7

210 George Street

Sydney, NSW 2010

Australia

Founded in 1999

Phone:

61 2 9247 2577

Fax:

61 2 9247 7344

Key Executives for Brandon Capital Partners

Founder and Venture Partner
Founding Partner, Managing Director, Director, and Partner
Managing Director, Founding Partner, and Principal Executive of MRCF
Age: 40
Chief Financial Officer
Investment Manager
Compensation as of Fiscal Year 2015.

Brandon Capital Partners Key Developments

Brandon Capital Partners Presents at Bio-Trinity, May-11-2015

Brandon Capital Partners Presents at Bio-Trinity, May-11-2015 . Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom.

Brandon Capital Closes an AUD 200 Million Life Science Venture Capital Fund for Medical Research Commercialization Fund

Brandon Capital announced that it has closed an AUD 200 million life science venture capital fund for the Medical Research Commercialization Fund (MRCF). Around AUD 50 million of the new fund will be reserved for 20-30 very early seed stage investments in promising biotech or medical device technologies. The remaining AUD 150 million will be reserved for supporting the most successful of these and existing MRCF portfolio companies to take these opportunities through to mid-stage clinical trials in patients. Finally, under the new fund structure, each of the superannuation investors have the opportunity to invest much larger amounts of capital (tens of millions) into the most promising assets as they mature.

Brandon Capital Partners Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

Brandon Capital Partners Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
June 29, 2015
Spinifex Pharmaceuticals Inc.
Private Placement
June 3, 2015
Auspherix Pty Ltd
Private Placement
June 2, 2015
Global Kinetics Corporation Limited
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Brandon Capital Partners, please visit www.brandoncapital.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.